Heather Avant always dresses up when she goes to the emergency room.
Contineum Therapeutics files for IPO with MS drug in Phase II
Clinical-stage biotech Contineum Therapeutics, which until recently went by the name Pipeline Therapeutics, on Friday revealed plans to go public under the Nasdaq ticker $CTNM.